Literature DB >> 8588961

Massive intercalary bone allografts in the treatment of primary and secondary bone tumors. A report on 21 cases.

G Voggenreiter1, W Klaes, S Assenmacher, K P Schmit-Neuerburg.   

Abstract

From 1981 to 1993, 21 patients received intercalary bone allografts for reconstruction of the extremity after en bloc tumor resection (15 malignant and 6 benign tumors). The allografts were collected from multiorgan donors and cryopreserved at -70 degrees C. The mean follow-up was 4.4 (range 1-13) years. The fate of the grafts was followed by conventional radiography, bone scintigraphy, and functional assessment. The overall survival rate of the 7 patients with high-grade malignancies was 86%. Solid union of the graft-host sites in less that 15 months occurred in 85%. An increased isotope uptake of the graft indicates that incorporation at the osteotomies as well as remodelling is still continuing at 9 years after operation. The overall complication rate was 43%; 3 patients had two or more complications. Complications were related to the allograft in 6 (infection or fatigue fracture in 1 and delayed healing in 4 cases) and to the osteosynthesis in 3 patients. The definitive results after treatment of complications show that satisfactory results have been obtained in all but 2 patients: 62% had excellent, 19% good, and 10% fair results. Intercalary allografts therefore provide a valuable solution for large skeletal defects after resection of bone tumors.

Entities:  

Mesh:

Year:  1995        PMID: 8588961     DOI: 10.1007/bf00448953

Source DB:  PubMed          Journal:  Arch Orthop Trauma Surg        ISSN: 0936-8051            Impact factor:   3.067


  26 in total

Review 1.  Chemotherapy for malignant bone tumors.

Authors:  N Jaffe
Journal:  Orthop Clin North Am       Date:  1989-07       Impact factor: 2.472

2.  The first 32 years of total hip arthroplasty. One surgeon's perspective.

Authors:  W H Harris
Journal:  Clin Orthop Relat Res       Date:  1992-01       Impact factor: 4.176

3.  Infection in bone allografts. Incidence, nature, and treatment.

Authors:  C F Lord; M C Gebhardt; W W Tomford; H J Mankin
Journal:  J Bone Joint Surg Am       Date:  1988-03       Impact factor: 5.284

4.  The use of allografts to reconstruct intercalary defects of long bones.

Authors:  J T Makley
Journal:  Clin Orthop Relat Res       Date:  1985 Jul-Aug       Impact factor: 4.176

5.  Effects of preservation and sterilization on cortical bone grafts. A scanning electron microscopic study.

Authors:  G Voggenreiter; R Ascherl; G Blümel; K P Schmit-Neuerburg
Journal:  Arch Orthop Trauma Surg       Date:  1994       Impact factor: 3.067

6.  Osteoarticular and intercalary allograft transplantation in the management of malignant tumors of bone.

Authors:  H J Mankin; S H Doppelt; T R Sullivan; W W Tomford
Journal:  Cancer       Date:  1982-08-15       Impact factor: 6.860

7.  A system for the surgical staging of musculoskeletal sarcoma.

Authors:  W F Enneking; S S Spanier; M A Goodman
Journal:  Clin Orthop Relat Res       Date:  1980 Nov-Dec       Impact factor: 4.176

8.  Bone changes in the vascularised fibular graft.

Authors:  H H de Boer; M B Wood
Journal:  J Bone Joint Surg Br       Date:  1989-05

9.  Titanium fibermetal segmental replacement prostheses. A radiographic analysis and review of current status.

Authors:  D A Heck; E Y Chao; F H Sim; D J Pritchard; T C Shives
Journal:  Clin Orthop Relat Res       Date:  1986-03       Impact factor: 4.176

10.  Intercalary bone allografts: radiographic evaluation.

Authors:  S V Kattapuram; W C Phillips; H J Mankin
Journal:  Radiology       Date:  1989-01       Impact factor: 11.105

View more
  3 in total

1.  Intercalary allograft reconstructions using a compressible intramedullary nail: a preliminary report.

Authors:  Benjamin J Miller; Walter W Virkus
Journal:  Clin Orthop Relat Res       Date:  2010-02-10       Impact factor: 4.176

Review 2.  How the Choice of Osteosynthesis Affects the Complication Rate of Intercalary Allograft Reconstruction? A Systematic Review and Meta-analysis.

Authors:  Khodamorad Jamshidi; Mansour Bahardoust; Arman Karimi Behnagh; Abolfazl Bagherifard; Alireza Mirzaei
Journal:  Indian J Orthop       Date:  2021-11-10       Impact factor: 1.251

3.  Antifracture efficacy and reduction of mortality in relation to timing of the first dose of zoledronic acid after hip fracture.

Authors:  Erik Fink Eriksen; Kenneth W Lyles; Cathleen S Colón-Emeric; Carl F Pieper; Jay S Magaziner; Jonathan D Adachi; Lars Hyldstrup; Chris Recknor; Lars Nordsletten; Catherine Lavecchia; Huilin Hu; Steven Boonen; Peter Mesenbrink
Journal:  J Bone Miner Res       Date:  2009-07       Impact factor: 6.741

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.